
CMS issued a rule finalizing certain telehealth and network adequacy proposals for Medicare Advantage and Part D prescription drug plans for contract years 2021 and 2022, as well as certain provisions of the Bipartisan Budget Act of 2018 and 21st Century Cures Act, among other changes. The agency plans to issue a separate final rule to address other remaining provisions of the proposed rule.